- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Purpose Bitcoin ETF
Silver47 Exploration
Rua Gold
Fidelity Advantage Bitcoin ETF
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Commercial Observer reported yesterday that New York is fast becoming a “viable alternative” to lab hubs in San Diego, San Francisco and Cambridge, Massachusetts. However, the city still has one key issue to overcome: lack of facilities.
Commercial Observer reported yesterday that New York is fast becoming a “viable alternative” to lab hubs in San Diego, San Francisco and Cambridge, Massachusetts. However, the city still has one key issue to overcome: lack of facilities.
As quoted in the market news:
‘New York’s got the science, it’s got the money; now it just needs the facilities,’ John Isaacs, an executive vice president at CBRE, told Commercial Observer.
New York’s 1.7 million square feet of life sciences space pales in comparison to the Boston/Cambridge region, which boasts some 20 million square feet of biotech space.
But the tide is turning. Already, the Alexandria Center for Life Science, a facility located on East 29th Street at the East River Science Park, has added over 700,000 square feet of lab space to the city and there is more on the way.
The EDC is helping too, and not just with funding. The city, in cooperation with the Department of Health, issued a request for proposals in December to developers for the redevelopment of 455 First Avenue. A redevelopment of that property would see the Department of Health, the building’s largest tenant, consolidate its space, freeing up five floors for new lab tenants.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.